Skip to content
Sunday, January 18, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Public Teachers Are Hijacking MLK Day With Palestinian Propaganda January 17, 2026
  • In Iran, Unlimited Courage Confronts Unlimited Cruelty January 16, 2026
  • Jewish caricature in Ukrainian Christmas tradition resurfaces at New Jersey church, drawing criticism January 16, 2026
  • Larry Ellison once renamed a superyacht because its name spelled backwards was ‘I’m a Nazi’ January 16, 2026
  • A Return to Tahiti and Life at Sea January 16, 2026
  • Rejecting Kahanists and rebuffing anti-Zionists, a new leader of the New Israel Fund makes its case for liberal democracy January 16, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.